SCHEMBL7376409

SCHEMBL7376409

[CH2]c1ccc2onc(CC)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.43
LMNA P02545 6/20 0.35
TP53 P04637 6/20 0.35
GRM4 Q14833 1/20 0.34
POLB P06746 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
MAOB P27338 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
HTR2C P28335 1/20 0.33
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26525546 0.80 MAPT (0.64) MAPTLMNATP53POLBHTR2C
SCHEMBL18512333 0.79 MAPT (0.43) MAPTLMNATP53GRM4POLB
SCHEMBL13180387 0.79 MAPT (0.44) MAPTLMNATP53POLBTDP1
SCHEMBL30895159 0.79 MAPT (0.43) MAPTLMNATP53GRM4POLB
SCHEMBL23639186 0.76 MAPT (0.41) MAPTLMNATP53GRM4POLB
SCHEMBL14588768 0.76 MAPT (0.41) MAPTLMNATP53ESR1ESR2
SCHEMBL7374829 0.76 GRM4 (0.40) MAPTGRM4ESR1ESR2
SCHEMBL18015728 0.75 EPHX2 (0.54) MAPTGRM4
SCHEMBL7375241 0.75 KCNA5 (0.38) MAPTESR1ESR2ACHE
SCHEMBL7376738 0.75 HTT (0.35) MAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO disclosed